ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents-Reference-Cited by-同舟云学术

ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents

Published:2015-03-27 Issue:18 Volume:6 Page:16611-16622
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Mancarella Caterina¹,Casanova-Salas Irene²,Calatrava Ana³,Ventura Selena¹,Garofalo Cecilia¹,Rubio-Briones José⁴,Magistroni Vera⁵,Manara Maria Cristina¹,López-Guerrero José Antonio²,Scotlandi Katia¹

Affiliation:

1. CRS Development of Biomolecular Therapies, Experimental Oncology Lab, Rizzoli Orthopaedic Institute, Bologna, Italy

2. Laboratory of Molecular Biology, Fundación Instituto Valenciano de Oncología, Valencia, Spain

3. Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain

4. Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain

5. Department of Health Sciences, University of Milano-Bicocca, Monza, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poly-l-glutamic acid modification modulates the bio-nano interface of a therapeutic anti-IGF-1R antibody in prostate cancer;Biomaterials;2023-10

2. The Relationship between IGF Pathway and Acquired Resistance to Tyrosine Kinase Inhibitors in Cancer Therapy;Frontiers in Bioscience-Landmark;2023-08-11

3. A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer;British Journal of Cancer;2023-08-03

4. Unraveling the IGF System Interactome in Sarcomas Exploits Novel Therapeutic Options;Cells;2021-08-13

5. Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy;Journal of Hematology & Oncology;2020-06-03